Here, for the first time, we found that FIGNL1 is highly expressed in human HCC and has a significant or partial correlation with the malignant prognosis and tumor stage of patients, indicating that FIGNL1 has the ability to become a strong predictor of the progression and prognosis in HCC patients. The gene discussed is FIGNL1; the disease is hepatocellular carcinoma.